n-(1-methyl-2-phenylethyl)adenosine has been researched along with haloperidol in 2 studies
Studies (n-(1-methyl-2-phenylethyl)adenosine) | Trials (n-(1-methyl-2-phenylethyl)adenosine) | Recent Studies (post-2010) (n-(1-methyl-2-phenylethyl)adenosine) | Studies (haloperidol) | Trials (haloperidol) | Recent Studies (post-2010) (haloperidol) |
---|---|---|---|---|---|
134 | 0 | 4 | 20,330 | 1,753 | 3,294 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bridges, AJ; Bristol, JA; Bruns, RF; Downs, DA; Heffner, TG; Moos, WH; Szotek, DL; Trivedi, BK | 1 |
Chopde, CT; Ghosh, AK; Mandhane, SN | 1 |
2 other study(ies) available for n-(1-methyl-2-phenylethyl)adenosine and haloperidol
Article | Year |
---|---|
N6-(2,2-diphenylethyl)adenosine, a novel adenosine receptor agonist with antipsychotic-like activity.
Topics: Adenosine; Animals; Antipsychotic Agents; Ataxia; Avoidance Learning; Dose-Response Relationship, Drug; Haloperidol; Motor Activity; Rats; Receptors, Purinergic; Structure-Activity Relationship; Thioridazine | 1987 |
Adenosine A2 receptors modulate haloperidol-induced catalepsy in rats.
Topics: 2-Chloroadenosine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Catalepsy; Dopamine Antagonists; Haloperidol; Male; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Rats; Rats, Wistar; Receptors, Purinergic P1; Scopolamine; Theobromine; Theophylline; Xanthines | 1997 |